| 注册
首页|期刊导航|临床与实验病理学杂志|MTAP和p16免疫组化染色联合应用于预测胶质瘤CDKN2A基因纯合性缺失

MTAP和p16免疫组化染色联合应用于预测胶质瘤CDKN2A基因纯合性缺失

田荣 蔡樱樱 王映梅 刘一雄 张丽英 李侠 叶菁 谷雨

临床与实验病理学杂志2026,Vol.42Issue(5):624-629,6.
临床与实验病理学杂志2026,Vol.42Issue(5):624-629,6.DOI:10.13315/j.cnki.cjcep.2026.05.009

MTAP和p16免疫组化染色联合应用于预测胶质瘤CDKN2A基因纯合性缺失

Combined application of MTAP and p16 immunohistochemical staining for predicting homozygous deletion of the CDKN2A gene in glioma

田荣 1蔡樱樱 2王映梅 1刘一雄 1张丽英 3李侠 1叶菁 1谷雨1

作者信息

  • 1. 空军军医大学第一附属医院/西京医院病理科,西安 710032||空军军医大学基础医学院病理学教研室,西安 710032
  • 2. 空军军医大学基础医学院学员二大队,西安 710032
  • 3. 空军军医大学基础医学院病理学教研室,西安 710032
  • 折叠

摘要

Abstract

Objective To investigate the sensitivity and specificity of the combined application of MTAP and p16 immunohistochemical(IHC)staining for predicting homozygous deletion(HD)of the CDKN2A gene in glioma.Methods Pathological tissue specimens from 54 patients with primary gliomas who underwent surgical resection were collected.HE staining and fluorescence in situ hybridization(FISH)for the CDKN2A gene were performed.The ex-pression patterns of p16 and MTAP protein were analyzed by IHC analysis,and their relationship with CDKN2A HD was evaluated.Results Among 54 glioma samples,the sensitivity,specificity,accuracy,and misdiagnosis rate of p16 IHC staining for predicting CDKN2A HD were 100%,65.3%,68.5%,and 31.5%,respectively,with a missed diagnosis rate of 0;the sensitivity,specificity,accuracy,and misdiagnosis rate of MTAP IHC staining for predicting CDKN2A HD were 100%,87.8%,88.9%,and 11.1%,respectively,with a missed diagnosis rate of 0.The com-bined use of p16 and MTAP IHC achieved 100%sensitivity,and 0 missed diagnosis rate,98.0%specificity,98.1%accuracy,and only a 1.9%false-positive rate in predicting CDKN2A HD.Conclusion Single p16 or MTAP immuno-histochemistry for determining homozygous deletion of CDKN2A gene has high sensitivity,but poor specificity and a certain misjudgment rate(higher misjudgment rate for p16 than MTAP).Their combined application significantly im-proves specificity,which is valuable for screening and partially replacing genomic testing.However,further FISH or NGS testing may be necessary for double negative gliomas with low-grade histology.

关键词

胶质瘤/CDKN2A/MTAP/p16

Key words

glioma/CDKN2A/MTAP/p16

分类

医药卫生

引用本文复制引用

田荣,蔡樱樱,王映梅,刘一雄,张丽英,李侠,叶菁,谷雨..MTAP和p16免疫组化染色联合应用于预测胶质瘤CDKN2A基因纯合性缺失[J].临床与实验病理学杂志,2026,42(5):624-629,6.

基金项目

国家自然科学基金(82173120)、肿瘤生物学国家重点实验室自主课题(CBSKL2022Z26) Project of Natural Science Foundation of China(82173120) (82173120)

Project of State Key Laboratory of Can-cer Biology(CBSKL2022Z26) (CBSKL2022Z26)

临床与实验病理学杂志

1001-7399

访问量0
|
下载量0
段落导航相关论文